Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Clinical trial NCT06705478 · SUSPENDED

Trial details

NCT number: NCT06705478
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Mild Neurocognitive Disorder HIV

Start date: 2026-05-17
Primary completion: 2026-12-02
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.